Company Filing History:
Years Active: 2014-2025
Title: Michelle Morrow: Innovator in Antibody Molecules
Introduction
Michelle Morrow is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. With a total of 9 patents to her name, her work focuses on innovative solutions for treating diseases such as cancer and infectious diseases.
Latest Patents
Among her latest patents is a groundbreaking application related to antibody molecules that bind CD137 and OX40. This invention involves antibody molecules that can agonize both CD and OX, featuring a CDR-based binding site for CD and an OX antigen-binding site located in a constant domain of the antibody molecule. These antibody molecules have potential applications in treating various diseases. Another notable patent is for bispecific binding proteins, which are designed to bind two epitopes. This disclosure includes specific binding proteins, such as antibodies, that target a protein of interest. The methods outlined in this patent aim to induce immune responses and provide treatments for cancer.
Career Highlights
Michelle has worked with notable companies in the biotechnology sector, including Medimmune Limited and Invox Pharma Limited. Her experience in these organizations has contributed to her expertise in antibody development and therapeutic applications.
Collaborations
Some of her coworkers include Scott A Hammond and Christophe Queva, who have collaborated with her on various projects in the field of biotechnology.
Conclusion
Michelle Morrow is a distinguished inventor whose work in antibody molecules has the potential to revolutionize treatments for serious diseases. Her innovative patents and collaborations highlight her significant impact on the biotechnology industry.